Target intelligence / Profile preview

Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3B (STT3B)

Target
STT3B
Molecular classification
Enzyme (specifically, a glycosyltransferase), Catalytic subunit of the oligosaccharyltransferase complex, Transmembrane protein
01

Overview

Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3B (STT3B) is a catalytic enzyme subunit of the oligosaccharyltransferase (OST) complex found in the endoplasmic reticulum membrane of eukaryotic cells[1][2][3][4][5]. Its main function is to catalyze the transfer of preassembled oligosaccharide chains from dolichyl-diphosphooligosaccharide donors onto asparagine residues within nascent polypeptides, a process called N-linked glycosylation[1][2][4]. Humans express two closely related OST catalytic subunits, STT3A and STT3B, which are assembled into distinct OST complexes and differ in substrate specificity and timing (co- vs post-translational modification)[1]. STT3B, in particular, mediates post-translational glycosylation of sites skipped by STT3A and acts independently of association with the protein translocation channel[1]. Mutations in STT3B can lead to congenital disorders of glycosylation and impact multiple systems due to insufficient protein glycosylation. STT3B is essential for proper protein folding and cell viability and represents a prototypical member of the glycosyltransferase family of enzymes that regulate glycoprotein expression, with implications in inherited and acquired disease[2][4].

Other names
STT3BDolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3BSIMPOligosaccharyl transferase subunit STT3BSTT3-BFLJ90106Source of immunodominant MHC-associated peptides homologCDG1XHomolog of yeast STT3Dolichyl-diphosphooligosaccharide protein glycotransferase
02

Mechanism of action

For potential or research inhibitors (e.g., tunicamycin): Inhibition of N-linked glycosylation by blocking dolichyl-diphosphooligosaccharide access or transfer activity of OST. Disruption of glycoprotein biosynthesis, leading to unfolded protein stress, ER stress, and apoptosis in susceptible cells.

03

Biological functions

N-linked glycosylation of proteins (transfer of oligosaccharides to asparagine residues)Protein maturation and folding in the endoplasmic reticulumCell proliferation (essential for cell viability)Influences the assembly and function of the oligosaccharyltransferase (OST) complex
04

Disease associations

Congenital disorders of glycosylation (CDG1X) (mutations lead to hereditary glycosylation disorders)Possible role in cancer and other diseases through effects on glycoprotein expressionPotential immunological relevance (contains minor histocompatibility antigen epitope)Other (rare syndromic and metabolic conditions involving protein glycosylation)
05

Safety considerations

Ubiquitous and essential activity—inhibition leads to widespread disruption of protein folding, cell viability, and organ dysfunctionToxicity—general inhibitors such as tunicamycin are toxic and cannot be selectively targeted to pathological tissueTherapeutic challenge—lack of highly specific modulators; broad effects on protein glycosylation increase off-target risks
06

Interacting drugs

tunicamycin
07

Biomarkers

Glycosylation status of specific proteins (e.g., presence of hypoglycosylated glycoproteins in patient serum)Mutational analysis of STT3B gene in congenital disordersMinor histocompatibility antigen (B6(dom1) epitope) in research contextClinical genetic diagnostic panels for CDG syndromes

Beyond the preview

Go deeper on Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3B (STT3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3B (STT3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call